Stock listing

LS Exchange:565131 Genmab A/S Aktie

German listing (LS Exchange) of Genmab A/S · home listing Copenhagen:GMAB

Follow Genmab A/S into a list and get an email when it puts out news.

Home listing price · OMXCOP:GMAB

2,542.00 DKK +40.00 (+1.6%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXCOP:GMAB

Since Jul 6, 2026 +39.1% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
2,473.00 – 2,576.00 DKKOct 19, 2026
Volume
104,214 sharesOct 19, 2026
Market value
156.3B DKKAt the close on Oct 19, 2026 · price × 61.49M shares outstanding
Genmab A/S logo
Ticker
LS Exchange:565131
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LS Exchange
Currency
EUR

What changed lately

Calls

Replays

  • Genmab (Copenhagen:GMAB) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 12:00 PM ET

    Watch Transcript

  • Genmab (Copenhagen:GMAB) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 12:00 PM ET

    Watch Transcript

  • Genmab (Copenhagen:GMAB) Q4 2025 Earnings Call

    Tue, Feb 17, 2026 · 12:00 PM ET

    Watch Transcript

Latest news

Genmab A/S Announces Rinatabart Sesutecan (Rina-S) Phase 2 RAINFOLTM-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer

Oct 3, 2026

Notice to Convene an Extraordinary General Meeting of Genmab A/S

Sep 8, 2026

Interim Report for the First Half of 2026

Aug 6, 2026

Genmab Announces Financial Results for the First Half of 2026

Aug 6, 2026

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026

Jul 15, 2026

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

Jul 6, 2026

Genmab A/S has published its Articles of Association

Jun 17, 2026

Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients

Jun 11, 2026

Major Shareholder Announcement

May 8, 2026

Genmab Announces Financial Results for the First Quarter of 2026

May 7, 2026

All Genmab A/S news

Decks

Genmab A/S on 6ix

Sector
Health care
Industry
Biotechnology
News releases
50 in the last 12 months · 70 in all · newest Oct 3, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Aug 6, 2026
Decks
16 decks · latest Aug 6, 2026

Where Genmab A/S is listed

ListingExchangeCountryCurrency
Copenhagen:GMAB · Home listingCopenhagenDenmarkDKK
NASDAQ:GMABNASDAQUnited StatesUSD
gettex:GE9gettexGermanyEUR
LSIN:0MGBLSINUnited KingdomDKK
OTC:GNMSFOTCUnited StatesUSD
Frankfurt:GE9FrankfurtGermanyEUR
Xetra:GE9XetraGermanyEUR
Tradegate:GE9TradegateGermanyEUR
VIE:GMABViennaAustriaEUR
LS Exchange:565131 · This pageLS ExchangeGermanyEUR
Aquis:GMABCAquisUnited KingdomDKK
Lang & Schwarz:565131Lang & SchwarzGermanyEUR
BMV:GMABNBMVMexicoMXN
BX Swiss:GMABBX SwissSwitzerlandCHF
gettex:GE91gettexGermanyEUR
Aquis:GMABCAquisUnited KingdomDKK
Hamburg:GE9HamburgGermanyEUR
Turquoise:GMABCTurquoiseUnited KingdomDKK
Dusseldorf:GE9DusseldorfGermanyEUR
Hanover:GE9HanoverGermanyEUR
Stuttgart:GE9StuttgartGermanyEUR
BIVA:GMABNBIVAMexicoMXN
BMV:GMAB1NBMVMexicoMXN
Lang & Schwarz:A1WZYBLang & SchwarzGermanyEUR
Munich:GE9MunichGermanyEUR
Stuttgart:GE91StuttgartGermanyEUR
BOATS:GMABBOATSUnited StatesUSD
Dusseldorf:GE91DusseldorfGermanyEUR
Frankfurt:GE91FrankfurtGermanyEUR
LS Exchange:A1WZYBLS ExchangeGermanyEUR
Munich:GE91MunichGermanyEUR
Tradegate:GE91TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Genmab A/S.